Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
$200/year or
consider an Enterprise subscription
.
Prescription Digital Therapeutics
All Newsletters
216 articles
2 of 22
FDA OKs Alivecor (12L?), Akili OTC. Oui eyes obesity.
6.21.24
5
min. Read
Digging into the Akili-Virtual Therapeutics deal
5.31.24
10
min. Read
CMS questions MedRhythms on InTandem
5.17.24
5
min. Read
MedRhythms-Alexion. Akili RCT for OTC.
4.26.24
6
min. Read
Hints about Otsuka’s commercialization plan for Rejoyn
4.16.24
6
min. Read
Better Therapeutics shuts down. Mahana-Cara Care
3.15.24
5
min. Read
HCPCS and CPT decisions. Akili results. Click trials
3.01.24
7
min. Read
De Novo: Samsung Galaxy Watch gets OTC sleep apnea detection
2.16.24
7
min. Read
Facebook’s RCT for AI bot Zenny. More trials
1.30.24
7
min. Read
FDA de novo for Google smartphone thermometer.
1.05.24
6
min. Read
1 of 22